HBSP (USA)
-
BeiGene
Shih, Willy; Zhang, JimmyCase HBS-618033-EStrategyBeiGene was a biopharmaceutical company founded on exploiting a temporal regulatory policy discontinuity. Because of regulatory challenges in China, most innovative new drugs launched there four to six years after their initial U.S. launches. This gave BeStarting at €8.20
-
BeiGene, PowerPoint Supplement
Shih, Willy; Zhang, JimmyCase HBS-618043-EStrategyPowerPoint slides for case 618033.Starting at €8.20
-
Cyprus (A)
Werker, Eric; Berardi, Sebastian; Elia, Stelios; Muakkassa, Omar; Zumberge, JamesCase HBS-714010-EEconomicsCyprus is a small Mediterranean island located at the cross-roads of Europe, Africa, and the Middle East. Since its 1974 split, Cyprus has grown real GDP more than fivefold-in large part because of its development as an "international business" center. The country developed a large network of double-taxation-treaties (including some of the most robust agreements with Russia and other ex-Soviet Republics) that allowed it to serve as a tax-efficien...Starting at €8.20
-
Cyprus (B)
Werker, Eric; Berardi, Sebastian; Elia, Stelios; Muakkassa, Omar; Zumberge, JamesCase HBS-714011-EEconomicsStarting at €5.74
-
Cyprus (A) and (B), Teaching Note
Werker, Eric; Berardi, Sebastian; Elia, Stelios; Muakkassa, Omar; Zumberge, JamesTeaching Note HBS-714012-EEconomicsTeaching Note for 714010 and 714011.Starting at €0.00
-
BeiGene, Teaching Note
Shih, Willy; Zhang, JimmyTeaching Note HBS-618039-EStrategyTeaching Note for 618033 BeiGene. BeiGene was a biopharmaceutical company founded on exploiting a temporal regulatory policy discontinuity. Because of regulatory challenges in China, most innovative new drugs launched there four to six years after their initial U.S. launches. This gave BeiGene a window of opportunity to develop drug candidates toward known targets with known mechanisms of actions that would allow it to become first-in-class in Ch...Starting at €0.00